The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations

Florian Krismer; Jose Alberto Palma; Giovanna Calandra-Buonaura; Iva Stankovic; Luca Vignatelli; Anna Karin Berger; Cristian Falup-Pecurariu; Alexandra Foubert-Samier; Günter Höglinger; Horacio Kaufmann; Larry Kellerman; Han Joon Kim; Thomas Klockgether; Johannes Levin; Pablo Martinez-Martin; Tiago A. Mestre; Maria Teresa Pellecchia; Susan Perlman; Irfan Qureshi; Olivier Rascol; Anette Schrag; Klaus Seppi; Huifang Shang; Glenn T. Stebbins; Gregor K. Wenning; Wolfgang Singer; Wassilios G. Meissner

doi:10.1002/mds.29215

The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations

Florian Krismer, Jose Alberto Palma, Giovanna Calandra-Buonaura, Iva Stankovic, Luca Vignatelli, Anna Karin Berger, Cristian Falup-Pecurariu, Alexandra Foubert-Samier, Günter Höglinger, Horacio Kaufmann, Larry Kellerman, Han Joon Kim, Thomas Klockgether, Johannes Levin, Pablo Martinez-Martin, Tiago A. Mestre, Maria Teresa Pellecchia, Susan Perlman, Irfan Qureshi, Olivier RascolAnette Schrag, Klaus Seppi, Huifang Shang, Glenn T. Stebbins, Gregor K. Wenning, Wolfgang Singer, Wassilios G. Meissner

Neurology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	2336-2341
Number of pages	6
Journal	Movement Disorders
Volume	37
Issue number	12
DOIs	https://doi.org/10.1002/mds.29215
State	Published - Dec 2022

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/mds.29215

Cite this

Krismer, F., Palma, J. A., Calandra-Buonaura, G., Stankovic, I., Vignatelli, L., Berger, A. K., Falup-Pecurariu, C., Foubert-Samier, A., Höglinger, G., Kaufmann, H., Kellerman, L., Kim, H. J., Klockgether, T., Levin, J., Martinez-Martin, P., Mestre, T. A., Pellecchia, M. T., Perlman, S., Qureshi, I., ... Meissner, W. G. (2022). The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations. Movement Disorders, 37(12), 2336-2341. https://doi.org/10.1002/mds.29215

Krismer, F, Palma, JA, Calandra-Buonaura, G, Stankovic, I, Vignatelli, L, Berger, AK, Falup-Pecurariu, C, Foubert-Samier, A, Höglinger, G, Kaufmann, H, Kellerman, L, Kim, HJ, Klockgether, T, Levin, J, Martinez-Martin, P, Mestre, TA, Pellecchia, MT, Perlman, S, Qureshi, I, Rascol, O, Schrag, A, Seppi, K, Shang, H, Stebbins, GT, Wenning, GK, Singer, W & Meissner, WG 2022, 'The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations', Movement Disorders, vol. 37, no. 12, pp. 2336-2341. https://doi.org/10.1002/mds.29215

@article{c9a6cc272593424f85563d7d91faca2d,

title = "The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations",

author = "Florian Krismer and Palma, {Jose Alberto} and Giovanna Calandra-Buonaura and Iva Stankovic and Luca Vignatelli and Berger, {Anna Karin} and Cristian Falup-Pecurariu and Alexandra Foubert-Samier and G{\"u}nter H{\"o}glinger and Horacio Kaufmann and Larry Kellerman and Kim, {Han Joon} and Thomas Klockgether and Johannes Levin and Pablo Martinez-Martin and Mestre, {Tiago A.} and Pellecchia, {Maria Teresa} and Susan Perlman and Irfan Qureshi and Olivier Rascol and Anette Schrag and Klaus Seppi and Huifang Shang and Stebbins, {Glenn T.} and Wenning, {Gregor K.} and Wolfgang Singer and Meissner, {Wassilios G.}",

note = "Funding Information: K.S.: Reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Gr{\"u}nenthal, Stada, Licher Pharma, Biogen, BIAL, and AbbVie; honoraria from the IPMDS; research grants from FWF Austrian Science Fund, The Michael J. Fox Foundation, and AOP Orphan Pharmaceuticals AG, outside the submitted work. Funding Information: H.S.: Research funding from the Sichuan Science and Technology Program (Grant 2022ZDZX0023). Funding Information: G.K.W. reports consultancy and lecture fees from AbbVie, Affiris, AstraZeneca, Biogen, Biohaven, Inhibicase, Lundbeck, Merz, Novartis, Ono, Teva, and Theravance; research grants from the FWF Austrian Science Fund, the Austrian National Bank, the US MSA Coalition, Parkinson Fonds Austria, and IPMDS, outside of the submitted work. Funding Information: G.T.S.: Consulting and Advisory Board Membership with honoraria: Adamas Pharmaceuticals, Ceregene, Inc., CHDI Management, Inc., Cleveland Clinic Foundation, Neurocrine Biosciences, Inc., Pfizer, Inc., Tools‐4‐Patients. Grants and Research: NIH, Department of Defense, The Michael J. Fox Foundation for Parkinson's Research, Dystonia Coalition, CHDI, IPMDS, Columbia University. Honoraria: IPMDS, American Academy of Neurology, The Michael J. Fox Foundation for Parkinson's Research, FDA, NIH, and Alzheimer's Association. Funding Information: T.A.M.: Consultancy/Speaker honorarium: AbbVie, IPMDS, AAN, AbbVie, CHDI Foundation/Management, Sunovion, Valeo Pharma, Roche, nQ. Medical advisory board: AbbVie, Biogen, Sunovion, Medtronic. Research funding: EU Joint Programme ‐ Neurodegenerative Disease Research, uOBMRI, Roche, Ontario Research Fund, CIHR, MJFF, Parkinson Canada, PDF/PSG, LesLois Foundation, PSI Foundation, Parkinson Research Consortium, and Brain Canada. Funding Information: A.S.: Research funding from GE Healthcare; honoraria for consultancy from Biogen, AbbVie, Roche, Bial, GE Healthcare; license fee payments from the University College London for the MSA‐QoL, PSP‐QoL, and PQolCarers; and royalties from Oxford University Press. ",

year = "2022",

month = dec,

doi = "10.1002/mds.29215",

language = "English (US)",

volume = "37",

pages = "2336--2341",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley and Sons Inc.",

number = "12",

}

TY - JOUR

T1 - The Unified Multiple System Atrophy Rating Scale

T2 - Status, Critique, and Recommendations

AU - Krismer, Florian

AU - Palma, Jose Alberto

AU - Calandra-Buonaura, Giovanna

AU - Stankovic, Iva

AU - Vignatelli, Luca

AU - Berger, Anna Karin

AU - Falup-Pecurariu, Cristian

AU - Foubert-Samier, Alexandra

AU - Höglinger, Günter

AU - Kaufmann, Horacio

AU - Kellerman, Larry

AU - Kim, Han Joon

AU - Klockgether, Thomas

AU - Levin, Johannes

AU - Martinez-Martin, Pablo

AU - Mestre, Tiago A.

AU - Pellecchia, Maria Teresa

AU - Perlman, Susan

AU - Qureshi, Irfan

AU - Rascol, Olivier

AU - Schrag, Anette

AU - Seppi, Klaus

AU - Shang, Huifang

AU - Stebbins, Glenn T.

AU - Wenning, Gregor K.

AU - Singer, Wolfgang

AU - Meissner, Wassilios G.

N1 - Funding Information: K.S.: Reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Grünenthal, Stada, Licher Pharma, Biogen, BIAL, and AbbVie; honoraria from the IPMDS; research grants from FWF Austrian Science Fund, The Michael J. Fox Foundation, and AOP Orphan Pharmaceuticals AG, outside the submitted work. Funding Information: H.S.: Research funding from the Sichuan Science and Technology Program (Grant 2022ZDZX0023). Funding Information: G.K.W. reports consultancy and lecture fees from AbbVie, Affiris, AstraZeneca, Biogen, Biohaven, Inhibicase, Lundbeck, Merz, Novartis, Ono, Teva, and Theravance; research grants from the FWF Austrian Science Fund, the Austrian National Bank, the US MSA Coalition, Parkinson Fonds Austria, and IPMDS, outside of the submitted work. Funding Information: G.T.S.: Consulting and Advisory Board Membership with honoraria: Adamas Pharmaceuticals, Ceregene, Inc., CHDI Management, Inc., Cleveland Clinic Foundation, Neurocrine Biosciences, Inc., Pfizer, Inc., Tools‐4‐Patients. Grants and Research: NIH, Department of Defense, The Michael J. Fox Foundation for Parkinson's Research, Dystonia Coalition, CHDI, IPMDS, Columbia University. Honoraria: IPMDS, American Academy of Neurology, The Michael J. Fox Foundation for Parkinson's Research, FDA, NIH, and Alzheimer's Association. Funding Information: T.A.M.: Consultancy/Speaker honorarium: AbbVie, IPMDS, AAN, AbbVie, CHDI Foundation/Management, Sunovion, Valeo Pharma, Roche, nQ. Medical advisory board: AbbVie, Biogen, Sunovion, Medtronic. Research funding: EU Joint Programme ‐ Neurodegenerative Disease Research, uOBMRI, Roche, Ontario Research Fund, CIHR, MJFF, Parkinson Canada, PDF/PSG, LesLois Foundation, PSI Foundation, Parkinson Research Consortium, and Brain Canada. Funding Information: A.S.: Research funding from GE Healthcare; honoraria for consultancy from Biogen, AbbVie, Roche, Bial, GE Healthcare; license fee payments from the University College London for the MSA‐QoL, PSP‐QoL, and PQolCarers; and royalties from Oxford University Press.

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85137570803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137570803&partnerID=8YFLogxK

U2 - 10.1002/mds.29215

DO - 10.1002/mds.29215

M3 - Article

C2 - 36074648

AN - SCOPUS:85137570803

SN - 0885-3185

VL - 37

SP - 2336

EP - 2341

JO - Movement Disorders

JF - Movement Disorders

IS - 12

ER -

The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this